Literature DB >> 21860417

Loss of LIN9, a member of the DREAM complex, cooperates with SV40 large T antigen to induce genomic instability and anchorage-independent growth.

S Hauser1, T Ulrich, S Wurster, K Schmitt, N Reichert, S Gaubatz.   

Abstract

The DREAM complex is an important regulator of mitotic gene expression during the cell cycle. Here we report that inactivation of LIN9, a subunit of DREAM, results in premature senescence, which can be overcome by the SV40 large T (LT) antigen. Together with the observation that p16(INK4a) and p21(Waf1) are upregulated upon loss of LIN9, these results indicate that senescence is triggered by the pRB and p53 tumor suppressor pathways. We also find that LIN9-null cells that escape senescence are chromosomally instable because of compromised mitotic fidelity. SV40 LT-expressing cells that adapt to the loss of LIN9 can grow anchorage-independently in soft agar, a hallmark of oncogenic transformation. Taken together, these results suggest an important role of mitotic gene regulation in the maintenance of genomic stability and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860417     DOI: 10.1038/onc.2011.364

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors.

Authors:  Jennifer M Sahni; Sylvia S Gayle; Bryan M Webb; Kristen L Weber-Bonk; Darcie D Seachrist; Salendra Singh; Steven T Sizemore; Nicole A Restrepo; Gurkan Bebek; Peter C Scacheri; Vinay Varadan; Matthew K Summers; Ruth A Keri
Journal:  Cancer Res       Date:  2017-08-14       Impact factor: 12.701

2.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

3.  LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance.

Authors:  Melyssa S Roberts; Jennifer M Sahni; Morgan S Schrock; Katrina M Piemonte; Kristen L Weber-Bonk; Darcie D Seachrist; Stefanie Avril; Lindsey J Anstine; Salendra Singh; Steven T Sizemore; Vinay Varadan; Matthew K Summers; Ruth A Keri
Journal:  Cancer Res       Date:  2020-02-13       Impact factor: 12.701

4.  Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.

Authors:  Martin Fischer; Marianne Quaas; Axel Wintsche; Gerd A Müller; Kurt Engeland
Journal:  Nucleic Acids Res       Date:  2013-09-25       Impact factor: 16.971

5.  Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.

Authors:  Martin Fischer; Sigrid Uxa; Clara Stanko; Thomas M Magin; Kurt Engeland
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

6.  Ovarian cancer proliferation and apoptosis are regulated by human transfer RNA methyltransferase 9-likevia LIN9.

Authors:  Huai Mei Chen; Jia Wang; Ying Feng Zhang; Yan Hong Gao
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

7.  DREAM represses distinct targets by cooperating with different THAP domain proteins.

Authors:  Csenge Gal; Francesco Nicola Carelli; Alex Appert; Chiara Cerrato; Ni Huang; Yan Dong; Jane Murphy; Andrea Frapporti; Julie Ahringer
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

8.  The role of the hippo pathway in melanocytes and melanoma.

Authors:  Ji Eun Kim; Graeme J Finlay; Bruce C Baguley
Journal:  Front Oncol       Date:  2013-05-16       Impact factor: 6.244

Review 9.  Thymic and Postthymic Regulation of Naïve CD4(+) T-Cell Lineage Fates in Humans and Mice Models.

Authors:  José E Belizário; Wesley Brandão; Cristiano Rossato; Jean Pierre Peron
Journal:  Mediators Inflamm       Date:  2016-05-30       Impact factor: 4.711

Review 10.  Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8+ T-cell activation and exhaustion.

Authors:  José Belizário; Maria Fernanda Destro Rodrigues
Journal:  Ther Adv Vaccines Immunother       Date:  2020-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.